VANCOUVER, British Columbia, Jan. 06, 2021 (GLOBE NEWSWIRE) -- WPD Pharmaceuticals Inc. (CSE: WBIO)(FSE: 8SV1) (the Company or WPD) a clinical-stage pharmaceutical company, is pleased to announce that it has engaged Image Analysis Group (IAG), a leading medical imaging company, to provide important critical imaging services during the Berubicin phase 2 clinical trials which are scheduled to start in February 2021.
IAG has deep expertise in partnering with global biotech companies to provide centralized reading and analysis of patient responses in real time. IAGs scientific and clinical imaging expertise in the field ofglioblastomamultiforme (GBM), coupled with IAGs proprietary Artificial Intelligence (AI) powered platform DYNAMIKA will allow WPD and its partners to review efficacy assessments, objective responses, and to thoroughly explore Berubicins effect in patients with GBM.
Advanced cancer therapies often lead to pseudo-progression, a local tissue reaction resulting from immune cell infiltration, causing inflammation, tumor necrosis and oedema which are often misinterpreted as tumor growth on traditional MRIs. Under the arrangement, IAG will utilize its advanced AI-driven methodologies that provide reliable early efficacy readouts. Pseudo-progression is difficult to distinguish from disease progression using routine clinical MRI assessments, and having IAGs advanced technology will be crucial for early detection and progression.
Mariusz Olejniczak, CEO of WPD commented, We are very pleased to partner with IAG to collaborate on the upcoming Berubicin trials and other studies including WPD101, if possible in the future. IAG has a strong track record of working with leading biotech companies to provide critical imaging collection, analysis, and assessment which is a very important part of our Berubicin phase 2 trials. We look forward to working with them leading up to and in preparation of the commencement of these Trials.
Olga Kubassova, CEO of IAG commented, We are pleased that IAGs unique focus on the use of quantitative imaging and AI will help accelerate WPDs development programs while reducing R&D costs, timelines, and uncertainties. This work will support the field of advanced cancer drug development as a whole and provide much needed treatment options to patients with glioblastoma.
Diana Dupont-Roettger, Chief Scientific Alliance Officer of IAG commented, The integration of advanced imaging and AI driven image analysis will prevent a false response assessment in patients experiencing pseudo-progression and thereby enhance the efficacy read out of Berubicin, avoid early patient drop-out and save costs. IAG is excited to collaborate with WPD and to support the clinical development with optimal imaging trial design, efficient imaging data management and response assessment.
About Image Analysis Group
Image Analysis Group (IAG) is a unique clinical development partner to life sciences companies. IAG broadly leverages its proprietary image analysis methodologies, power of our cloud platform DYNAMIKA, years of experience in AI and Machine Learning as well as bespoke co-development business models to ensure higher probability for promising therapeutics to reach the patients. IAGs independent Bio-Partnering division fuses risk-sharing business models and agile culture to accelerate novel drug development.
About WPD Pharmaceuticals
WPD is a biotechnology research and development company with a focus on oncology and virology, namely research and development of medicinal products involving biological compounds and small molecules. WPD has licensed in certain countries 10 novel drug candidates with 4 that are in clinical development stage. These drug candidates were researched at medical institutions, and WPD currently has ongoing collaborations with Wake Forest University and leading hospitals and academic centers in Poland.
WPD has entered into license agreements with Wake Forest University Health Sciences and sublicense agreements with Moleculin Biotech, Inc. and CNS Pharmaceuticals, Inc., respectively, each of which grant WPD an exclusive, royalty-bearing sublicense to certain technologies of the licensor. Such agreements provide WPD with certain research, development, manufacturing and sales rights, among other things. The sublicense territory from CNS Pharmaceuticals and Moleculin Biotech includes for most compounds 30 countries in Europe and Asia, including Russia.
On Behalf of the Board
Mariusz Olejniczak
Mariusz Olejniczak CEO, WDP Pharmaceuticals
Contact:
Investor Relations Email: investors@wpdpharmaceuticals.com Tel: 604-428-7050 Web: http://www.wpdpharmaceuticals.com
Cautionary Statements:
Neither the Canadian Securities Exchange nor the Investment Industry Regulatory Organization of Canada accepts responsibility for the adequacy or accuracy of this release.
This press release contains forward-looking statements. Forward-looking statements are statements that contemplate activities, events or developments that the Company anticipates will or may occur in the future. Forward-looking statements in this press release include that IAGs technology will enhance our analysis of the effects of Berubicin, that we may partner with IAG regarding our other compounds and that WPDs drugs could be developed into novel treatments for cancer. These forward-looking statements reflect the Companys current expectations based on information currently available to management and are subject to a number of risks and uncertainties that may cause outcomes to differ materially from those projected. Factors which may prevent the forward looking statement from being realized is that the IAG technology may not provide the benefits expected and we may not engage them further; competitors or others may successfully challenge a granted patent and the patent could be rendered void; that we are unable to raise sufficient funding for our research; that we may not meet the requirements to receive the grants awarded; that our drugs dont provide positive treatment, or if they do, the side effects are damaging; competitors may develop better or cheaper drugs; and we may be unable to obtain regulatory approval for any drugs we develop. Readers should refer to the risk disclosure included from time-to-time in the documents the Company files on SEDAR, available at http://www.sedar.com. Although the Company believes that the assumptions inherent in these forward-looking statements are reasonable, they are not guarantees of future performance and, accordingly, they should not be relied upon and there can be no assurance that any of them will prove to be accurate. Finally, these forward-looking statements are made as of the date of this press release and the Company assumes no obligation to update them except as required by applicable law.
Read this article:
- Researchers create innovative verification techniques to increase security in artificial intelligence and image processing - European Research Council - April 29th, 2024 [April 29th, 2024]
- Who in Europe is investing the most in artificial intelligence? - Euronews - April 29th, 2024 [April 29th, 2024]
- 4 Artificial Intelligence (AI) Stocks Members of Congress Can't Stop Buying (and Nvidia Isn't 1 of Them!) - The Motley Fool - April 29th, 2024 [April 29th, 2024]
- The Standard Names Porter Orr Second Vice President of Artificial Intelligence Strategy and Development - NRToday.com - April 29th, 2024 [April 29th, 2024]
- Meet Nvidia CEO Jensen Huang, the man behind the $2 trillion company powering today's artificial intelligence - CBS News - April 29th, 2024 [April 29th, 2024]
- This Warren Buffett Dividend King Stock Just Invested $1.1 Billion Into Artificial Intelligence (AI) - The Motley Fool - April 29th, 2024 [April 29th, 2024]
- Joe Rogan Reveals What Could Be 'Game Over for the Human Race' - Newsweek - April 29th, 2024 [April 29th, 2024]
- LegalTech Artificial Intelligence Market to Soar to $6.4 Billion by 2028: Global Long-term Forecast to 2033 - Strategic ... - Yahoo Finance UK - April 29th, 2024 [April 29th, 2024]
- Artificial Intelligence Tokens Stumble Again! Is The AI Hype Over? - Coinpedia Fintech News - April 29th, 2024 [April 29th, 2024]
- CISA unveils guidelines for AI and critical infrastructure - FedScoop - April 29th, 2024 [April 29th, 2024]
- IBM's Webinar: Cybersecurity In The Era Of Artificial Intelligence Keynotes - AiThority - April 29th, 2024 [April 29th, 2024]
- Being and becoming a good doctor in the age of artificial intelligence - Firstpost - April 29th, 2024 [April 29th, 2024]
- Pope to take part in G7 summit in June to talk Artificial Intelligence - Crux Now - April 29th, 2024 [April 29th, 2024]
- Pope Francis to attend G7 summit to speak on artificial intelligence - Catholic News Agency - April 29th, 2024 [April 29th, 2024]
- 1 Unstoppable Artificial Intelligence (AI) Stock to Buy and Hold Forever - Yahoo Finance - April 29th, 2024 [April 29th, 2024]
- Pope to bring his call for ethical artificial intelligence to G7 summit in June in southern Italy - The Associated Press - April 29th, 2024 [April 29th, 2024]
- Elon Musk Called Tesla an Artificial Intelligence (AI) Robotics Company. Does That Make It a Buy? - The Motley Fool - April 29th, 2024 [April 29th, 2024]
- Emulating neurodegeneration and aging in artificial intelligence systems - Tech Xplore - April 29th, 2024 [April 29th, 2024]
- Pope Francis to participate in G7 session on AI - Vatican News - English - April 29th, 2024 [April 29th, 2024]
- A Once-in-a-Generation Investment Opportunity: 1 Bill Ackman Artificial Intelligence (AI) Stock to Buy Hand Over Fist ... - Yahoo Finance - April 29th, 2024 [April 29th, 2024]
- Tesla Stock Investors Cheer Progress on Its Artificial Intelligence (AI) Future - Yahoo Finance - April 29th, 2024 [April 29th, 2024]
- In Race to Build A.I., Tech Plans a Big Plumbing Upgrade - The New York Times - April 29th, 2024 [April 29th, 2024]
- A Baltimore-area teacher is accused of using AI to make his boss appear racist - NPR - April 29th, 2024 [April 29th, 2024]
- 3 Top Artificial Intelligence (AI) Stocks That Billionaires Jim Simons, Ray Dalio, and Israel Englander Are Buying - The Motley Fool - April 29th, 2024 [April 29th, 2024]
- The iPad Pro can give us a big surprise with its artificial intelligence chips. - Softonic EN - April 29th, 2024 [April 29th, 2024]
- This Artificial Intelligence (AI) Stock Could Soar 70%, According to Wall Street. Time to Buy? - Yahoo Finance - April 29th, 2024 [April 29th, 2024]
- Billionaire Bill Ackman Owns 8 Stocks -- and This Hypergrowth Artificial Intelligence (AI) Stock Isn't One of Them - The Motley Fool - April 29th, 2024 [April 29th, 2024]
- Artificial Intelligence Has Come for Our...Beauty Pageants? - Glamour - April 29th, 2024 [April 29th, 2024]
- 3 Stocks to Grab Now to Ride the Artificial Intelligence Chip Boom to Riches - InvestorPlace - April 29th, 2024 [April 29th, 2024]
- Is ASML's Big Sell-off a Warning Sign to Artificial Intelligence (AI) Investors? - The Motley Fool - April 29th, 2024 [April 29th, 2024]
- 3 Artificial Intelligence (AI) Stocks to Buy With $1,150 and Hold for Decades - Yahoo Finance - March 22nd, 2024 [March 22nd, 2024]
- This combines the power of artificial intelligence with human insights - finews.com - March 22nd, 2024 [March 22nd, 2024]
- Cohere Targets $5 Billion Valuation for ChatGPT Rival - PYMNTS.com - March 22nd, 2024 [March 22nd, 2024]
- IMF: Artificial Intelligence (AI) Will Transform 40% of Jobs. Can Investors Capitalize? - Yahoo Finance - March 22nd, 2024 [March 22nd, 2024]
- Cathie Wood Is Selling These 2 Artificial Intelligence (AI) Stocks. Should You? - Yahoo Finance - March 22nd, 2024 [March 22nd, 2024]
- iShares Robotics and Artificial Intelligence Multisector ETF (NYSEARCA:IRBO) Shares Acquired by Creative Financial ... - Defense World - March 22nd, 2024 [March 22nd, 2024]
- Inaugural Plenary Meeting of States Endorsing the Political Declaration on Responsible Military Use of Artificial ... - Department of State - March 22nd, 2024 [March 22nd, 2024]
- AMD Fell Today -- Is This a Chance to Buy the Artificial Intelligence (AI) Stock? - Yahoo Finance - March 22nd, 2024 [March 22nd, 2024]
- Artificial Intelligence (AI) Stocks Are Red-Hot, but Here's 1 to Avoid (for Now) - The Motley Fool - March 22nd, 2024 [March 22nd, 2024]
- A Once-in-a-Generation Investment Opportunity: 1 Artificial Intelligence (AI) Growth Stock to Buy and Hold Forever - Yahoo Finance - March 22nd, 2024 [March 22nd, 2024]
- 2 Artificial Intelligence (AI) Stocks That Could Go Parabolic - The Motley Fool - March 22nd, 2024 [March 22nd, 2024]
- Artificial intelligence will radically improve health care, but only if managed carefully - The Hill - March 22nd, 2024 [March 22nd, 2024]
- Tennessee Makes A.I. an Outlaw to Protect Its Country Music and More - The New York Times - March 22nd, 2024 [March 22nd, 2024]
- When Using Artificial Intelligence In Pharma R&D, Start With Identifying Problem To Solve - HBW Insight - March 22nd, 2024 [March 22nd, 2024]
- Why Super Micro Computer, Advanced Micro Devices, and Other Artificial Intelligence (AI) Stocks Tumbled on Tuesday - Yahoo Finance - March 22nd, 2024 [March 22nd, 2024]
- 3 Billionaires Are Selling Artificial Intelligence (AI) Stock Nvidia and Buying These 10 AI Stocks Instead - The Motley Fool - March 22nd, 2024 [March 22nd, 2024]
- Nvidia Just Bought 5 Artificial Intelligence (AI) Stocks. These 2 Stand Out the Most. - The Motley Fool - March 22nd, 2024 [March 22nd, 2024]
- UN adopts first global artificial intelligence resolution - ARMENPRESS - March 22nd, 2024 [March 22nd, 2024]
- This New Artificial Intelligence (AI) Chip Is a Massive Game Changer for Nvidia Stock - The Motley Fool - March 22nd, 2024 [March 22nd, 2024]
- Nvidia Led the First Phase of Artificial Intelligence (AI), but These 2 Growth Stocks Will Lead the Next Phases ... - The Motley Fool - March 22nd, 2024 [March 22nd, 2024]
- Meet Wall Street's Newest Stock-Split Stock, Along With the Artificial Intelligence (AI) Stock Likeliest to Follow in Its ... - The Motley Fool - March 22nd, 2024 [March 22nd, 2024]
- Amid Rumors of a Deal With Rivian, Apple Acquired This Artificial Intelligence (AI) Start-Up Instead - Yahoo Finance - March 22nd, 2024 [March 22nd, 2024]
- UN adopts first global artificial intelligence resolution - CGTN - March 22nd, 2024 [March 22nd, 2024]
- 1 No-Brainer Artificial Intelligence (AI) Stock to Buy With $25 and Hold for 10 Years - The Motley Fool - March 22nd, 2024 [March 22nd, 2024]
- 2 Artificial Intelligence (AI) Stocks That Could Make You a Millionaire - The Motley Fool - March 22nd, 2024 [March 22nd, 2024]
- Is Intel the Best Artificial Intelligence (AI) Semiconductor Stock to Buy Before It Skyrockets? - The Motley Fool - February 20th, 2024 [February 20th, 2024]
- The greater social implications of artificial intelligence - New Day NW - KING5.com - February 20th, 2024 [February 20th, 2024]
- AI comes to the world of beauty as eyelash robot uses artificial intelligence to place fake lashes - Fox News - February 20th, 2024 [February 20th, 2024]
- Beyer Appointed To Bipartisan Task Force On Artificial Intelligence - Falls Church News Press - February 20th, 2024 [February 20th, 2024]
- Why Did Nvidia Invest in These 5 Artificial Intelligence (AI) Stocks? Should You Buy Them, Too? - The Motley Fool - February 20th, 2024 [February 20th, 2024]
- Three key themes on artificial intelligence - Research Information - February 20th, 2024 [February 20th, 2024]
- How Artificial Intelligence is transforming consumerism - WFLA - February 20th, 2024 [February 20th, 2024]
- SAP names Philipp Herzig as chief artificial intelligence officer - CIO - February 20th, 2024 [February 20th, 2024]
- Unleashing the Power of Artificial Intelligence: Transforming Web-Based Applications for Enhanced Efficiency and User ... - Financialbuzz.com - February 20th, 2024 [February 20th, 2024]
- Koch Industries continues to accelerate its artificial intelligence initiative - The Business Journals - February 20th, 2024 [February 20th, 2024]
- Forget Nvidia: These 3 Artificial Intelligence (AI) Stocks Can Be the Next Stock-Split Stocks - The Motley Fool - February 20th, 2024 [February 20th, 2024]
- Artificial Intelligence for small business focus of upcoming JWCC Lunch and Learn on Feb. 28 Muddy River News - Muddy River News - February 20th, 2024 [February 20th, 2024]
- Opponents Highlight the Environmental Impact of Artificial Intelligence - News-Press Now - February 20th, 2024 [February 20th, 2024]
- Generative AI's environmental costs are soaring and mostly secret - Nature.com - February 20th, 2024 [February 20th, 2024]
- Chapter Summary: Genesis of Artificial Intelligence and a Scientific Revolution: 1950-1979 - EIN News - February 20th, 2024 [February 20th, 2024]
- What would Thomas Aquinas make of Artificial Intelligence? - ACI Africa - February 20th, 2024 [February 20th, 2024]
- ChatGPT Predicted Bitcoin Price Will "Skyrocket" - Cryptonews - February 20th, 2024 [February 20th, 2024]
- Worried About an Artificial Intelligence (AI) Stock Bubble? Consider This Billionaire Investor's Advice. - Yahoo Finance - February 20th, 2024 [February 20th, 2024]
- This Super Artificial Intelligence (AI) Stock Could Be at the Beginning of a Terrific Bull Run - Yahoo Finance - February 20th, 2024 [February 20th, 2024]
- 5 Artificial Intelligence (AI) Stocks That Could Make You a Millionaire - Yahoo Finance - February 20th, 2024 [February 20th, 2024]
- Will AI replace Colorado teachers? Here's what experts say. - The Colorado Sun - February 20th, 2024 [February 20th, 2024]
- Nvidia Could Be About to Counter a Big Artificial Intelligence (AI) Threat With This Move - Yahoo Finance - February 20th, 2024 [February 20th, 2024]
- The Healthiest U.S. Pharma Companies: Ranked by RealRate's Impressive Artificial Intelligence - Medium - February 20th, 2024 [February 20th, 2024]
- Down 84%, Is This Artificial Intelligence (AI) Stock a Buy After an Earnings Pop? - The Motley Fool - February 20th, 2024 [February 20th, 2024]
- 'AI for Humans' may be the most entertaining way to learn about artificial intelligence - Fast Company - February 20th, 2024 [February 20th, 2024]